XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference

Core Viewpoint - XOMA Royalty Corporation will present a company update at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025 [1][2]. Company Overview - XOMA Royalty Corporation is a biotechnology royalty aggregator that aids biotech companies in improving human health by acquiring potential future economics associated with therapeutic candidates licensed to pharmaceutical or biotechnology firms [3]. - The company provides non-dilutive, non-recourse funding to sellers, allowing them to advance their internal drug candidates or for general corporate purposes [3]. - XOMA Royalty has a growing portfolio of assets, defined as the rights to receive potential future economics linked to the advancement of underlying therapeutic candidates [3].